A CCL21 gene-modified dendritic cell vaccine combined with pembrolizumab in advanced non-small cell lung cancer: a phase I trial

Oh MS, Lisberg AE, Dumitras C, Tran LM, Salehi-Rad R, Krysan K, Lim RJ, Shabihkhani M, Romero T, Li S, Zeng W, Jing Z, Li R, Kahangi BP, Tsvetkova O, Suh RD, Abtin F, Genshaft SJ, Oh SS, Fishbein GA, Greenwald DR, Kahlon KS, Anand SR, Ashouri S, Goldman JW, Lee JM, Zhou XJ, Elashoff DA, Garon EB, Liu B, Dubinett SM. A CCL21 gene-modified dendritic cell vaccine combined with pembrolizumab in advanced non-small cell lung cancer: a phase I trial. Nat Commun. 2026 Oct 4;17(1):11321. doi: 10.1038/s41467-026-78130-7. PMID: 42967950; PMCID: PMC13724721.


Related Posts